Answers are grounded in this paper and cite their sources.
Narrative review highlights neuromodulation strategies for treating drug-resistant epilepsy in children, suggesting critical gaps in evidence.
Neuromodulation has emerged as a promising therapeutic strategy for drug-resistant epilepsy. For several modalities, long-term follow-up data are now available in adults; however, high-level evidence supporting their use in children remains limited. Vagus nerve stimulation has long been used to treat drug-resistant epilepsy in both adults and children. In contrast, responsive neurostimulation and deep brain stimulation are not formally approved for pediatric use worldwide, although they are offered off-label in select healthcare systems. This narrative review summarizes the current literature on neuromodulation for pediatric epilepsy, focusing on mechanisms of action, efficacy, patient selection, and safety.
No takes yet. Share an insight, caveat, or question.
Hyoung Won Choi (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: